Login
Subscribe
Tuberculosis Can Emerge After Cancer Immunotherapy
Tuberculosis Can Emerge After Cancer Immunotherapy
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
Keytruda
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Sukanya Charuchandra | Jun 4, 2018 | 2 min read
Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.
Gene Mutations Foretell Immunotherapy Response
Aggie Mika | Jun 12, 2017 | 2 min read
A drug that blocks an immune checkpoint protein effectively treats tumors in patients with deficient DNA repair genes.